ScoreCardiology
DAPT score (dual antiplatelet therapy beyond 1 year)
Estimates whether extending dual antiplatelet therapy beyond 12 months after PCI gives more ischaemic benefit than bleeding risk.
Updated 30 October 2026
When to use it
Patients with a coronary stent who have completed about 12 months of dual antiplatelet therapy without major ischaemic or bleeding events.
What it needs
- Age
- Current cigarette smoker
- Diabetes mellitus
- Myocardial infarction at index presentation
- Prior PCI or prior myocardial infarction
- Paclitaxel-eluting stent
- Stent diameter < 3 mm
- Congestive heart failure or LVEF < 30 %
- Vein graft PCI
The points for each answer and the automatic total are in the app.
How to interpret it
| Result | Interpretation |
|---|---|
| ≤ 1 | Unfavourable balance for extended dual therapy |
| ≥ 2 | Favourable balance for extended dual therapy |
Practical tip
Only applies to patients who tolerated 12 months of dual therapy without bleeding or ischaemic events; it does not set the initial duration.
3 more practical tips in the app.
Reference
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
